312,721 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
rz9179 |
5 |
3 |
1 |
5 |
3 |
3 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
male |
8 |
4/17/25, 11:19 AM |
312,722 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
AL9417 |
5 |
3 |
5 |
5 |
5 |
3 |
1 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
male |
8 |
4/17/25, 11:21 AM |
312,723 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
bw9243 |
5 |
3 |
5 |
5 |
3 |
5 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
male |
8 |
4/17/25, 11:24 AM |
312,724 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
fb9391 |
5 |
5 |
5 |
5 |
3 |
5 |
3 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
male |
8 |
4/17/25, 11:25 AM |
312,725 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
ro9165 |
3 |
3 |
5 |
5 |
5 |
3 |
3 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
female |
8 |
4/17/25, 11:26 AM |
312,726 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
jm9041 |
5 |
3 |
5 |
5 |
3 |
1 |
1 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
male |
8 |
4/17/25, 11:27 AM |
312,727 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
lf9059 |
3 |
5 |
5 |
5 |
5 |
5 |
3 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
female |
8 |
4/17/25, 11:28 AM |
312,728 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
si9330 |
3 |
3 |
3 |
5 |
5 |
1 |
5 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
male |
8 |
4/17/25, 11:30 AM |
312,729 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
jb9288 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
male |
8 |
4/17/25, 11:31 AM |
312,730 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
va9410 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
female |
8 |
4/17/25, 11:32 AM |
312,731 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
jr9442 |
1 |
1 |
3 |
1 |
1 |
5 |
3 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
male |
8 |
4/17/25, 11:32 AM |
312,732 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
mm0943 |
3 |
5 |
3 |
3 |
3 |
1 |
3 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
male |
8 |
4/17/25, 11:33 AM |
312,733 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
ng9117 |
3 |
5 |
1 |
5 |
3 |
5 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
female |
8 |
4/17/25, 11:33 AM |
312,734 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
bm9426 |
3 |
5 |
5 |
5 |
5 |
3 |
5 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
female |
8 |
4/17/25, 11:35 AM |
312,735 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
tw9340 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
female |
8 |
4/17/25, 11:36 AM |
312,736 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
ag9409 |
5 |
3 |
1 |
5 |
3 |
1 |
5 |
3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
male |
8 |
4/17/25, 11:37 AM |
312,737 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
tw9340 |
5 |
3 |
5 |
1 |
3 |
5 |
1 |
3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
male |
8 |
4/17/25, 11:41 AM |
312,738 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
fr9060 |
5 |
3 |
1 |
5 |
3 |
3 |
5 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
female |
8 |
4/17/25, 11:52 AM |
312,739 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
mr9202 |
5 |
5 |
5 |
5 |
5 |
3 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
female |
8 |
4/17/25, 11:53 AM |
312,740 |
12 |
Edison 2nd Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
jm9252 |
3 |
5 |
1 |
5 |
3 |
5 |
3 |
3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
female |
8 |
4/17/25, 11:54 AM |